Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02192567 : Open Label Study of DS-5573a
PhasePhase 1
AgesMin: 20 Years Max: N/A
Eligibility
Inclusion Criteria:

- Advanced solid tumor that is refractory to standard treatment, or for which no
standard treatment is available.

- Eastern Cooperative Oncology Group performance status(PS) of 0 or 1

Exclusion Criteria:

- Have any of the following concomitant disease or had the history of having following
disease within 6 months before enrollment:

Cardiac failure (NYHA ? ClassIII), myocardial infarction, cerebral infarction, unstable
angina, arrhythmia requiring treatment, coronary-artery/peripheral artery bypass surgery,
cerebrovascular disease, pulmonary thromboembolism, uncontrolled deep-vein thrombosis or
clinically severe thromboembolic event, or autoimmune disorders requiring treatment.

- Severe or uncontrolled concomitant disease.

- Clinically active brain metastases defined as symptomatic or requiring treatment.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02192567      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740